You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (31)

Journals (0)

1-10 of 31 results for rearranged during transfection (RET)

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Open access

Research article

First published 2024-01

Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield [...]

Thyroid®

Select article: A contemporary review of rearranged during transfection-selective inhibitors

Retricted access

Review article

First published 2022-1

A contemporary review of rearranged during transfection-selective inhibitors

Angel W Liu, Connie Liang, Chung-Shien Lee

Journal of Oncology Pharmacy Practice

Select article: Current management of RET rearranged non-small cell lung cancer

Open access

Review article

First published 2020

Current management of RET rearranged non-small cell lung cancer

Thomas E Stinchcombe

Therapeutic Advances in Medical Oncology

Select article: Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China

Open access

Review article

First published 2023

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China

Tao Li, Wen-Yu Yang, Ting-Ting Liu [...]

Technology in Cancer Research & Treatment

Select article: Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report

Open access

Case report

First published 2022-6

Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report

Xiangming Cao, Xiongwei Liu, Simin Wang [...]

Journal of International Medical Research

Select article: Correction to : Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study’’ by Subbiah et al. Thyroid 2024;34(1):26–40;doi: 10.1089/thy.2023.0363

Retricted access

Correction

First published 2025-07

Correction to : Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study’’ by Subbiah et al. Thyroid 2024;34(1):26–40;doi: 10.1089/thy.2023.0363

Thyroid®

Select article: Precision oncology with selective RET inhibitor selpercatinib in RET -rearranged cancers

Open access

Review article

First published 2023

Precision oncology with selective RET inhibitor selpercatinib in RET -rearranged cancers

Mohamed A. Gouda, Vivek Subbiah

Therapeutic Advances in Medical Oncology

Select article: Efficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report

Open access

Case report

First published 2026

Efficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report

Shiwei Chen, He Wang, Qi Shen [...]

Therapeutic Advances in Endocrinology and Metabolism

Select article: Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer

Open access

Review article

First published 2012

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer

Nils Degrauwe, Julie Ann Sosa, Sanziana Roman [...]

Clinical Medicine Insights: Oncology

Select article: RET kinase inhibitors for RET -altered thyroid cancers

Open access

Review article

First published 2022

RET kinase inhibitors for RET -altered thyroid cancers

Danica M. Vodopivec, Mimi I. Hu

Therapeutic Advances in Medical Oncology

1
2
3
4
10 / page

Article type

Publication date

Subjects

Access